Vivimed Sprayable Sunscreen Formulation Formula Ref. 2-016-23

Vivimed Labs Ltd
Phase
Product
INCI Name
Supplier
Volume
A
Arlacel 165
Glyceryl Stearate (and) PEG-100 Stearate
Croda
1.50
Span 60
Sorbitan Stearate
Croda
1.00
Crodamol DA
Diisopropyl Adipate
Croda
5.00
Finsolv EB
Ethylhexyl Benzoate
Innospec
10.00
Xiameter PMX200 /100cs
Dimethicone
Dow Corning
1.00
Avis
Butyl Methoxydibenzoylmethane
Vivimed
5.00
Octyne-B
Octocrylene
Vivimed
3.00
OMC
Ethyl Hexyl Methoxycinnamate
Vivimed
4.00
Titriplex III
Disodium EDTA
Merck
0.10
RonaCare AP
Bis-ethylhexyl Hydroxydimethoxy Benzylmalonate
Merck
1.00
B
Deionised Water
Aqua
38.20
Pricerine 9091
Glycerine
Various
3.00
Veegum Ultra
Magnesium Aluminium Silicate
Vanderbilt
0.40
Keltrol CG-RD
Xanthan Gum
CP Kelco
0.10
Crodafos MCK
Potassium Cetyl Phosphate
Croda
3.00
C
Solaveil XT-40W
Titanium Dioxide (and) Aqua (and) Polyglyceryl-2 Caprate (and) Sucrose Stearate (and) Simmondsia Chinensis (Jojoba) Seed Oil (and) Stearic Acid (and) Alumina (and) Glyceryl Caprylate (and) Squalane
Croda
8.00
D
Deionised Water
Aqua
10.00
Vivsonic
Phenylbenzimidazole Sulfonic Acid
Vivimed
2.00
Triethanolamine 90%
Triethanolamine
Various
1.20
E
SolPerForm 100
Aqua (and) Hydrolysed Wheat Protein/PVP Crosspolymer
Croda
2.00
Nipaguard BPX
Phenoxyethanol (and) Methylparaben (and) Propylparaben (and) 2-Bromo-2-Nitropropane-1,3-Diol
Clariant
0.50

Preparation:

1. Combine glycerine, Keltrol and Veegum. Add water with stirring. 2. Once dispersed, add Crodafos MCK and heat to 75-80°C. 3. Combine oil phase ingredients (part A) and heat to 75-80°C. 4. Add oil phase to water phase with stirring. 5. Add Solaveil XT-40W with vigorous stirring. 6. Homogenise for 2 minutes. 7. Allow to cool with stirring. 8. Prepare phase D, stirring until fully dissolved. Add phase D to emulsion at 40-50°C. 9. Add phase E ingredients below 40°C. Continue cooling with stirring to room temperature. 10. Check pH and adjust if necessary to pH 7 - 7.5.

Notes:

Test Data: 6280cps / pH7 / in-vitro SPF17 / UVA:UVB ratio 0.919
Disclaimer

While every effort has been made to reproduce these formulations correctly, the Publisher of this website cannot accept any liability for the information presented. All formulations are provided in good faith, but no warranty is given as to accuracy of information or results, or suitability for a particular use, nor is freedom from patent infringement to be inferred. Formulations are offered solely for consideration by the participating manufacturers. Continued use of this web site infers acceptance of this disclaimer.

Latest Issues

ROELMI HPC

At ROELMI HPC, we transcend industry standards, paving the way for innovation and excellence in the world of well-being and beyond.
We strongly focus our activity on the research, design and production of innovative actives and functional ingredients to offer sustainable solutions through an ethical and responsible choice.
 

Learn more »

in-cosmetics Asia 2025

BITEC, Bangkok, Thailand
4th - 6th November 2025

SCS Formulate 2025

Coventry Building Society Arena, UK
11th - 12th November 2025